IMMX
Immix Biopharma, Inc.5.94
-0.27-4.27%
Dec 16, 4:00:01 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
313.01MP/E (TTM)
-Basic EPS (TTM)
-0.77Dividend Yield
0%Recent Filings
8-K
8-K
8-K
10-Q
8-K
Immix raises $9.1M via private placement
Immix Biopharma closed a private placement on September 5, 2025, selling 3,831,216 common shares at $2.37 each for ~$9.1 million in gross proceeds, plus non-transferable warrants for 2,873,417 shares at $2.00 exercisable over ten years. Funds will support working capital and general corporate purposes, bolstering the biotech's operational runway amid development efforts. The board appointed Nancy Chang, Ph.D., effective September 8, adding expertise in antiviral drug development and biotech leadership. Warrants lock in long-term investor commitment.
IBRX
ImmunityBio, Inc.
2.16-0.06
IMA
ImageneBio, Inc.
6.25+0.08
IMMP
Immutep Limited
2.49+0.05
IMRX
Immuneering Corporation
5.74-0.04
IMTX
Immatics N.V.
10.09+0.11
INMB
INmune Bio Inc.
1.89-0.02
LRMR
Larimar Therapeutics, Inc.
3.74-0.18
MRKR
Marker Therapeutics, Inc.
1.27-0.12
TCRX
TScan Therapeutics, Inc.
0.95-0.01
TIL
Instil Bio, Inc.
11.25+0.13